A detailed history of Cubist Systematic Strategies, LLC transactions in Accolade, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 474,984 shares of ACCD stock, worth $1.64 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
474,984
Previous 260,040 82.66%
Holding current value
$1.64 Million
Previous $930,000 96.56%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.4 - $4.42 $730,809 - $950,052
214,944 Added 82.66%
474,984 $1.83 Million
Q2 2024

Aug 14, 2024

BUY
$3.58 - $10.13 $681,617 - $1.93 Million
190,396 Added 273.38%
260,040 $930,000
Q1 2024

May 15, 2024

BUY
$9.22 - $15.02 $642,117 - $1.05 Million
69,644 New
69,644 $729,000
Q2 2023

Aug 14, 2023

BUY
$10.52 - $16.06 $1,641 - $2,505
156 New
156 $2,000
Q4 2022

Feb 14, 2023

BUY
$7.19 - $13.16 $15,091 - $27,622
2,099 Added 3.62%
60,051 $467,000
Q3 2022

Nov 14, 2022

BUY
$0.0 - $12.8 $0 - $113,702
8,883 Added 18.1%
57,952 $662,000
Q2 2022

Aug 15, 2022

SELL
$5.28 - $18.9 $216,369 - $774,503
-40,979 Reduced 45.51%
49,069 $363,000
Q1 2022

May 16, 2022

BUY
$12.92 - $27.18 $751,194 - $1.58 Million
58,142 Added 182.23%
90,048 $1.58 Million
Q4 2021

Feb 14, 2022

BUY
$21.96 - $42.69 $182,970 - $355,693
8,332 Added 35.34%
31,906 $841,000
Q3 2021

Nov 15, 2021

BUY
$41.3 - $54.56 $374,095 - $494,204
9,058 Added 62.4%
23,574 $994,000
Q2 2021

Aug 16, 2021

BUY
$38.61 - $55.0 $512,238 - $729,685
13,267 Added 1062.21%
14,516 $788,000
Q1 2021

May 17, 2021

BUY
$38.1 - $59.09 $47,586 - $73,803
1,249 New
1,249 $57,000
Q4 2020

Feb 16, 2021

SELL
$33.26 - $59.72 $504,520 - $905,892
-15,169 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$0.55 - $41.34 $8,342 - $627,086
15,169 New
15,169 $590,000

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $248M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.